Optas LLC’s Zimmer Biomet ZBH Stock Holding History

Optas LLC’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,298	Closed	-$208K	–	558
2026 Q1	$208K	Buy	+2,298	New	+$211K	0.03%	445

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Optas LLC's ZBH Position: Q2 2026 in Review

Optas LLC sold out of Zimmer Biomet (ZBH) in Q2 2026, closing a stake of 2,298 shares — an estimated $208K sold.

Optas LLC first reported a position in ZBH in Q1 2026 and held it in 1 quarter. The position peaked at $208K in Q1 2026. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Optas LLC reported no remaining Zimmer Biomet position as of Q2 2026 after selling out during the quarter.
Optas LLC sold 2,298 Zimmer Biomet shares in Q2 2026, an estimated $208K.
Optas LLC first reported a position in Zimmer Biomet in Q1 2026 and held it in 1 quarter.
Optas LLC's Zimmer Biomet position peaked at $208K in Q1 2026.
906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Optas LLC's 13F filing for Q2 2026, filed 21 Jul 2026.